Skip to content

Kotler Kevin 13F Holdings · last filed Q4 2025

Kotler Kevin reported 34 securities worth $427.50M in its SEC 13F filing for Q4 2025 (period ended 2025-12-31). Top holdings: SPY (55.83%), AVDL (8.17%), QQQ (7.18%). Among its top 25 positions this quarter: 25 new.

RankTickerCompanyValue% PortfolioSharesAction
1SPYSPDR S&P 500 ETF TR$238.7M55.83%350,000New
2AVDLAVADEL PHARMACEUTICALS PLC$34.9M8.17%1.6MNew
3QQQINVESCO QQQ TR$30.7M7.18%50,000New
4ANGOANGIODYNAMICS INC$22.0M5.15%1.7MNew
5AUPHAURINIA PHARMACEUTICALS INC$19.5M4.57%1.2MNew
6OMEROMEROS CORP$19.3M4.53%1.1MNew
7NPCENEUROPACE INC$9.7M2.28%631,468New
8MDWDMEDIWOUND LTD$6.2M1.46%337,236New
9AXGNAXOGEN INC$5.5M1.29%168,000New
10IARTINTEGRA LIFESCIENCES HLDGS C$5.3M1.24%427,445New
11ACRSACLARIS THERAPEUTICS INC$5.1M1.20%1.7MNew
12EVTLVERTICAL AEROSPACE LTD$5.0M1.17%939,705New
13OSURORASURE TECHNOLOGIES INC$4.4M1.02%1.8MNew
14LKFTGALAPAGOS NV$2.9M0.69%90,000New
15LLYELI LILLY & CO$2.1M0.50%2,000New
16CERSCERUS CORP$2.1M0.49%1.0MNew
17NKENIKE INC$2.0M0.48%32,000New
18TECXTECTONIC THERAPEUTIC INC$1.7M0.39%80,000New
19CLYMCLIMB BIO INC$1.6M0.37%400,000New
20TMCITREACE MED CONCEPTS INC$1.2M0.27%474,365New
21TLSITRISALUS LIFE SCIENCES INC$1.0M0.24%145,200New
22DXCMDEXCOM INC$995,5500.23%15,000New
23VNDAVANDA PHARMACEUTICALS INC$882,0000.21%100,000New
24ALGNALIGN TECHNOLOGY INC$680,6580.16%4,359New
25OKURONKURE THERAPEUTICS INC$573,3040.13%197,691New

Source: SEC Form 13F filings · as of 2025-12-31

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR